Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions.
Publication
, Journal Article
Robb, MA; McInnes, PM; Califf, RM
Published in: JAMA
March 15, 2016
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 15, 2016
Volume
315
Issue
11
Start / End Page
1107 / 1108
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Terminology as Topic
- Pharmaceutical Preparations
- National Institutes of Health (U.S.)
- Genetic Markers
- General & Internal Medicine
- Equipment and Supplies
- Consensus
- Biomarkers
Citation
APA
Chicago
ICMJE
MLA
NLM
Robb, M. A., McInnes, P. M., & Califf, R. M. (2016). Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions. JAMA, 315(11), 1107–1108. https://doi.org/10.1001/jama.2016.2240
Robb, Melissa A., Pamela M. McInnes, and Robert M. Califf. “Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions.” JAMA 315, no. 11 (March 15, 2016): 1107–8. https://doi.org/10.1001/jama.2016.2240.
Robb MA, McInnes PM, Califf RM. Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions. JAMA. 2016 Mar 15;315(11):1107–8.
Robb, Melissa A., et al. “Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions.” JAMA, vol. 315, no. 11, Mar. 2016, pp. 1107–08. Pubmed, doi:10.1001/jama.2016.2240.
Robb MA, McInnes PM, Califf RM. Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions. JAMA. 2016 Mar 15;315(11):1107–1108.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 15, 2016
Volume
315
Issue
11
Start / End Page
1107 / 1108
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Terminology as Topic
- Pharmaceutical Preparations
- National Institutes of Health (U.S.)
- Genetic Markers
- General & Internal Medicine
- Equipment and Supplies
- Consensus
- Biomarkers